Skip to main content
Log in

Exhaled nitric oxide from the central airway and alveoli in OSAHS patients: the potential correlations and clinical implications

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Background

The aim of the study was to evaluate exhaled nitric oxide (eNO) derived from different areas of airway in obstructive sleep apnea hypopnea syndrome (OSAHS) patients with NO exchange model and investigate the potential application and interpretation of eNO in clinical setting.

Methods

This study was divided into two parts. Firstly, we performed a case control study in 32 OSAHS patients and 27 non-OSAHS participants. Fractional eNO (FeNO) and eNO from the central airway (J’awNO) and from alveoli (CANO) were compared in OSAHS and control groups. Also, correlation of eNO to severity of OSAHS was analyzed. Secondly, a prospective study was conducted in 30 severe OSAHS patients who received a short-term nasal continuous positive airway pressure (nCPAP) treatment. We evaluated eNO, plasma ET-1 concentration, and echocardiography during the treatment process and explored the potential relationship among them.

Results

FeNO and J’awNO were higher in OSAHS and associated with disease severity, while CANO was relatively lower. After nCPAP treatment in severe OSAHS patients, FeNO and J’awNO decreased and CANO increased significantly. Substantial agreement was shown between the elevation of CANO and the decrease of plasma ET-1 concentration after nCPAP by Kappa analysis for consistency. Tei index, which is considered indicative of global right ventricular function, might be predicted by plasma ET-1 levels in severe OSAHS patients.

Conclusions

NO exchange model provides us with more information of eNO derived from different areas. eNO is not only confirmed to be an effective method for airway inflammation evaluation in the follow-up of OSAHS, CANO may also serve as a useful marker in monitoring endothelial function, resistance of pulmonary circulation, and right ventricular function for clinical implication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Yaggi HK, Strohl KP (2010) Adult obstructive sleep apnea/hypopnea syndrome: definitions, risk factors, and pathogenesis. Clin Chest Med 31:179–186

    Article  PubMed  Google Scholar 

  2. Ryan S, McNicholas WT (2008) Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Arch Physiol Biochem 114:261–266

    Article  CAS  PubMed  Google Scholar 

  3. Selmi C, Montano N, Furlan R, Keen CL, Gershwin ME (2007) Inflammation and oxidative stress in obstructive sleep apnea syndrome. Exp Biol Med (Maywood) 232:1409–1413

    Article  CAS  Google Scholar 

  4. Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J 85:693–698

    Article  CAS  PubMed  Google Scholar 

  5. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053

    Article  PubMed  Google Scholar 

  6. Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev CD001106

  7. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. Available from: http://www.ginasthma.org/. Accessed on 2014 Dec 30

  8. George SC, Hogman M, Permutt S, Silkoff PE (2004) Modeling pulmonary nitric oxide exchange. J Appl Physiol (1985) 96:831–839

    Article  CAS  Google Scholar 

  9. Tsoukias NM, George SC (1998) A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol (1985) 85:653–666

    CAS  Google Scholar 

  10. Morris SJ, Billiar TR (1994) New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266:E829–E839

    CAS  PubMed  Google Scholar 

  11. Fortuna AM, Miralda R, Calaf N, Gonzalez M, Casan P, Mayos M (2011) Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome. Respir Med 105:630–636

    Article  CAS  PubMed  Google Scholar 

  12. Foresi A, Leone C, Olivieri D, Cremona G (2007) Alveolar-derived exhaled nitric oxide is reduced in obstructive sleep apnea syndrome. Chest 132:860–867

    Article  CAS  PubMed  Google Scholar 

  13. American Thoracic Society, European Respiratory Society (2005) ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 171:912–930

    Article  Google Scholar 

  14. Johns M (1998) Rethinking the assessment of sleepiness. Sleep Med Rev 2:3–15

    Article  CAS  PubMed  Google Scholar 

  15. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee (1997) Practice parameters for the indications for polysomnography and related procedures. Sleep 20:406–422

    Google Scholar 

  16. Ishizawa K, Yoshizumi M, Tsuchiya K, Houchi H, Minakuchi K, Izawa Y, Kanematsu Y, Kagami S, Hirose M, Tamaki T (2004) Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertens Res 27:433–440

    Article  CAS  PubMed  Google Scholar 

  17. American Thoracic Society (1995) Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152:1107–1136

    Article  Google Scholar 

  18. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, Seward JB (1995) New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy. J Cardiol 26:357–366

    CAS  PubMed  Google Scholar 

  19. Olopade CO, Christon JA, Zakkar M, Hua C, Swedler WI, Scheff PA, Rubinstein I (1997) Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111:1500–1504

    Article  CAS  PubMed  Google Scholar 

  20. Culla B, Guida G, Brussino L, Tribolo A, Cicolin A, Sciascia S, Badiu I, Mietta S, Bucca C (2010) Increased oral nitric oxide in obstructive sleep apnoea. Respir Med 104:316–320

    Article  PubMed  Google Scholar 

  21. Salerno FG, Carpagnano E, Guido P, Bonsignore MR, Roberti A, Aliani M, Vignola AM, Spanevello A (2004) Airway inflammation in patients affected by obstructive sleep apnea syndrome. Respir Med 98:25–28

    Article  CAS  PubMed  Google Scholar 

  22. Boyd JH, Petrof BJ, Hamid Q, Fraser R, Kimoff RJ (2004) Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med 170:541–546

    Article  PubMed  Google Scholar 

  23. Inancli HM, Enoz M (2010) Obstructive sleep apnea syndrome and upper airway inflammation. Recent Patents Inflamm Allergy Drug Discov 4:54–57

    Article  CAS  Google Scholar 

  24. Carpagnano GE, Spanevello A, Sabato R, Depalo A, Turchiarelli V, Foschino BM (2008) Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome. Transl Res 151:45–50

    Article  CAS  PubMed  Google Scholar 

  25. Depalo A, Carpagnano GE, Spanevello A, Sabato R, Cagnazzo MG, Gramiccioni C, Foschino-Barbaro MP (2008) Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects. J Intern Med 263:70–78

    Article  CAS  PubMed  Google Scholar 

  26. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H (2005) Oxidative stress in obstructive sleep apnea. Chest 127:1674–1679

    Article  CAS  PubMed  Google Scholar 

  27. Tanaka T, Nakamura H, Yodoi J, Bloom ET (2005) Redox regulation of the signaling pathways leading to eNOS phosphorylation. Free Radic Biol Med 38:1231–1242

    Article  CAS  PubMed  Google Scholar 

  28. Lui MM, Lam DC, Ip MS (2013) Significance of endothelial dysfunction in sleep-related breathing disorder. Respirology 18:39–46

    Article  PubMed  Google Scholar 

  29. Feng J, Zhang D, Chen B (2012) Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath 16:283–294

    Article  PubMed  Google Scholar 

  30. Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7:677–685

    PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no competing interests.

Funding

This research was supported by the Shanghai Leading Academic Discipline Project (B115), National Natural Science Foundation of China (81400043, 81100048, 81300055), Key Medical Grant from Shanghai Science and Technology Committee (13430720500), and Grant from Ministry of Education of China (20130071110044).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chunxue Bai.

Additional information

Yuanlin Song, Shanqun Li and Chunxue Bai contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Li, Z., Liu, Z. et al. Exhaled nitric oxide from the central airway and alveoli in OSAHS patients: the potential correlations and clinical implications. Sleep Breath 20, 145–154 (2016). https://doi.org/10.1007/s11325-015-1198-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-015-1198-7

Keywords

Navigation